Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors.
Casaos J, Huq S, Lott T, Felder R, Choi J, Gorelick N, Peters M, Xia Y, Maxwell R, Zhao T, Ji C, Simon T, Sesen J, Scotland SJ, Kast RE, Rubens J, Raabe E, Eberhart CG, Jackson EM, Brem H, Tyler B, Skuli N. Casaos J, et al. Among authors: huq s. Oncotarget. 2018 Jan 3;9(8):8054-8067. doi: 10.18632/oncotarget.23883. eCollection 2018 Jan 30. Oncotarget. 2018. PMID: 29487714 Free PMC article.
The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?
Casaos J, Gorelick NL, Huq S, Choi J, Xia Y, Serra R, Felder R, Lott T, Kast RE, Suk I, Brem H, Tyler B, Skuli N. Casaos J, et al. Among authors: huq s. Mol Cancer Ther. 2019 Jul;18(7):1185-1194. doi: 10.1158/1535-7163.MCT-18-0666. Mol Cancer Ther. 2019. PMID: 31263027 Review.
Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma.
Huq S, Casaos J, Serra R, Peters M, Xia Y, Ding AS, Ehresman J, Kedda JN, Morales M, Gorelick NL, Zhao T, Ishida W, Perdomo-Pantoja A, Cecia A, Ji C, Suk I, Sidransky D, Brait M, Brem H, Skuli N, Tyler B. Huq S, et al. Mol Cancer Ther. 2020 Sep;19(9):1797-1808. doi: 10.1158/1535-7163.MCT-19-0572. Epub 2020 Jun 30. Mol Cancer Ther. 2020. PMID: 32606016
Preclinical efficacy of ribavirin in SHH and group 3 medulloblastoma.
Huq S, Kannapadi NV, Casaos J, Lott T, Felder R, Serra R, Gorelick NL, Ruiz-Cardozo MA, Ding AS, Cecia A, Medikonda R, Ehresman J, Brem H, Skuli N, Tyler BM. Huq S, et al. J Neurosurg Pediatr. 2021 Feb 5;27(4):482-488. doi: 10.3171/2020.8.PEDS20561. J Neurosurg Pediatr. 2021. PMID: 33545678
Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
Medikonda R, Choi J, Pant A, Saleh L, Routkevitch D, Tong L, Belcaid Z, Kim YH, Jackson CM, Jackson C, Mathios D, Xia Y, Shah PP, Patel K, Kim T, Srivastava S, Huq S, Ehresman J, Pennington Z, Tyler B, Brem H, Lim M. Medikonda R, et al. Among authors: huq s. J Neurosurg. 2021 Aug 13;136(2):379-388. doi: 10.3171/2021.1.JNS202482. Print 2022 Feb 1. J Neurosurg. 2021. PMID: 34388730
242 results